Compare OBDC & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBDC | TFX |
|---|---|---|
| Founded | 2015 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.8B |
| IPO Year | 2015 | 1994 |
| Metric | OBDC | TFX |
|---|---|---|
| Price | $10.85 | $133.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | $14.00 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 3.6M | 430.2K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 13.40% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | N/A | $15.97 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.52 | $100.18 |
| 52 Week High | $15.19 | $139.67 |
| Indicator | OBDC | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 45.72 | 57.96 |
| Support Level | $10.61 | $118.39 |
| Resistance Level | $11.27 | $135.55 |
| Average True Range (ATR) | 0.23 | 3.82 |
| MACD | 0.01 | 0.80 |
| Stochastic Oscillator | 39.20 | 81.36 |
Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.